The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Rheumatoid arthritis and the complement system
Open accessAbstract
Complement activation contributes to a pathological process in a number of autoimmune and inflammatory diseases, including rheumatoid arthritis (RA). In this review we summarize current knowledge of complement contribution to RA, based on clinical observations in patients and in vivo animal models, as well as on experiments in vitro aiming at elucidation of underlying molecular mechanisms. There is strong evidence that both the classical and the alternative pathways of complement are pathologically activated during RA as well as in animal models for RA. The classical pathway can be initiated by several triggers present in the inflamed joint such as deposited autoantibodies, dying cells, and exposed cartilage proteins such as fibromodulin. B cells producing autoantibodies, which in turn form immune complexes, contribute to RA pathogenesis partly via activation of complement. It appears that anaphylatoxin C5a is the main product of complement activation responsible for tissue damage in RA although deposition of membrane attack complex as well as opsonization with fragments of C3b are also important. Success of complement inhibition in the experimental models described so far encourages novel therapeutic approaches to the treatment of human RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Cited by
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
“Here we address some emerging aspects of complement in health and disease, while referring to specialized reviews for detailed coverage of its role in rheumatoid arthriti”
BackgroundComplement, a target for therapy in inflammatory and degenerative diseases
Morgan, B. P., & Harris, C. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4657 · Cited by 431
Complement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364
Self-citationDNA hypomethylation in rheumatoid arthritis synovial fibroblasts
Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S., & Neidhart, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25018 · Cited by 308
Antigenicity of Bovine Pericardium Determined by a Novel Immunoproteomic Approach
Gates, K. V., Dalgliesh, A. J., & Griffiths, L. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-02719-8 · Cited by 29
Metadata
- Authors
- Okroj, M., Heinegård, D., Holmdahl, R., & Blom, A. M.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 39
- Issue
- 7
- Pages
- 517-530
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W1996584569
- Cited by
- 184
- References
- 1
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rheumatoid arthritis and the complement system. https://app.cochat.ai/papers/10.1080/07853890701477546
- The paper
- Okroj, M., Heinegård, D., Holmdahl, R., & Blom, A. M. (2007). Rheumatoid arthritis and the complement system. Annals of Medicine. https://doi.org/10.1080/07853890701477546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.